Senior Expert Engineer: Medical Devices & Autoinjectors

Novartis; Österreich; On-site; EUR 61,000 - 96,000; Full time

Benefits offered by this job

Hybrid working options

Health insurance

Wellbeing resources

Parental leave

Job summary

Novartis in Schaftenau, Austria is seeking an Expert Engineer in the Global Device and Packaging Development (GDPD) team to develop parenteral combination products and ensure high-quality delivery systems. The role collaborates with engineers and scientists across functions in a fast-paced environment.

You will work on device constituents, prefilled syringes integration, and life cycle management, contributing to design controls, regulatory readiness, and readiness for clinical trials and

Qualifications

• Bachelor, Master or PhD in engineering or equivalent.
• 2+ years of experience in development of medical devices and/or combination products; pharma experience preferred.
• Experience in developing plastic and metal components; tolerance analysis, modelling and testing.
• Excellent English skills, verbal and written; German advantageous.

Responsibilities

• Deliver technical development and life-cycle management in cross-functional teams for easy-to-use, safe and robust products.
• Responsible for device parts of an autoinjector and integration of prefilled syringes with the autoinjector into a combination product; ensure timely delivery of technical aspects and LCM.

Skills

Engineering

Medical device development

Cross-functional teamwork

English proficiency

Education

Bachelor/Master/PhD in engineering

Job description

Novartis in Schaftenau, Austria is seeking an Expert Engineer in the Global Device and Packaging Development (GDPD) team to develop parenteral combination products and ensure high-quality delivery systems. The role collaborates with engineers and scientists across functions in a fast-paced environment.

You will work on device constituents, prefilled syringes integration, and life cycle management, contributing to design controls, regulatory readiness, and readiness for clinical trials and